A BILL to amend and reenact § 8.01-622.1 of the Code of Virginia and to amend the Code of Virginia by adding in Chapter 29 of Title 54.1 an article numbered 11, consisting of sections numbered 54.1-2999 through 54.1-2999.9, relating to health care; decision-making; end of life; penalties.
HB886 would create a new Virginia statutory framework authorizing “medical aid in dying” for certain terminally ill adults, while also revising Virginia’s existing prohibition on assisted suicide. Under the bill, an eligible patient must be at least 18, a Virginia resident, diagnosed with a terminal disease expected to cause death within six months, and determined to have capacity to make an informed decision. The patient would need to make oral and written requests, receive counseling on diagnosis, prognosis, alternatives such as hospice and palliative care, and wait periods, and have the request witnessed by a qualified individual. The attending provider could then prescribe or dispense a self-administered controlled substance intended to end the patient’s life, and the bill specifies how the request, counseling, and documentation process must work.
The bill also sets out detailed rules on liability, immunity, and institutional authority. It would protect providers and health care entities acting in good faith under the article from civil, criminal, and professional discipline, while preserving penalties for coercion, forgery, concealment, or other unauthorized interference with a patient’s request. It would require death certificates to list the underlying terminal disease rather than suicide or homicide when the act is carried out under the article, and it would bar insurers from denying or altering benefits because a person requests or uses medical aid in dying. The bill further allows health care entities to adopt policies prohibiting the practice on their premises and to sanction providers who violate those policies.
In addition to creating the new article in Title 54.1, HB886 amends § 8.01-622.1 to clarify that the state’s assisted-suicide injunction and damages provisions do not apply to lawful pain relief, withdrawal of life-prolonging treatment, or properly administered medications without intent to cause death. The bill also directs the Board of Medicine to adopt regulations on witness qualifications for long-term care residents and acceptable residency documents, and it requires the Board to collect and publish nonidentifying annual statistics on compliance. It includes criminal penalties for coercion and tampering, with Class 2 felony treatment for certain acts that alter or force a patient’s request or rescission.
The overall sentiment reflected in the bill’s procedural history is cautious and unresolved rather than clearly supportive or opposed. HB886 was referred to the House Committee for Courts of Justice and later continued to the next session by voice vote, which suggests the committee did not move it forward during the session. No recorded floor votes or committee transcript excerpts are provided, so there is no direct evidence of debate positions, but the bill’s subject matter indicates a highly sensitive end-of-life policy issue likely to draw strong views from both advocates for patient autonomy and opponents concerned about assisted suicide and abuse.
The main points of contention are likely to be the legalization of physician-assisted death, the scope of provider participation, and the safeguards against coercion and undue influence. The bill attempts to address those concerns through waiting periods, capacity review, witness requirements, criminal penalties, and institutional opt-out provisions, but those same features may also be debated as either insufficient protection or overly restrictive. The inclusion of insurance protections, death-certificate rules, and explicit exclusions for elder abuse and homicide also suggests the bill is designed to anticipate legal and ethical objections.
HB886 would substantially change Virginia law by creating a new Article 11 in Title 54.1 authorizing medical aid in dying for qualifying terminally ill adults and by revising existing assisted-suicide law in § 8.01-622.1 to carve out conduct permitted under the new article and related end-of-life care. It would affect physicians, physician assistants, nurse practitioners, pharmacists, hospitals, hospices, nursing homes, insurers, the Board of Medicine, and the Board of Pharmacy, while also creating new criminal offenses and civil remedies for coercion, forgery, and interference with a patient’s request. The bill would also require new regulatory action and reporting by state licensing boards and would alter how deaths under the article are certified and recorded.
The available legislative history suggests the bill was met with caution and did not advance in the committee process, as it was continued to the next session by voice vote in the House Committee on Courts of Justice. Because there are no transcript excerpts or recorded roll-call votes, the precise balance of support and opposition is not documented here. Still, the bill’s detailed safeguards and liability provisions indicate an attempt to address anticipated concerns about abuse, coercion, and institutional participation, while its core purpose reflects support for end-of-life choice and patient autonomy among its sponsor and likely proponents.
The central controversy is whether Virginia should permit medical aid in dying at all, especially for terminally ill adults who self-administer a prescribed controlled substance to end life. Opponents are likely to focus on the moral and legal implications of assisted death, the risk of coercion or pressure on vulnerable patients, and the possibility that the practice could be expanded beyond the intended scope. Supporters are likely to emphasize autonomy, relief from suffering, and the bill’s procedural safeguards. Additional points of contention include whether health care providers and institutions should be allowed to opt out, whether the waiting periods and capacity-review requirements are sufficient, and whether the bill’s death-certificate and insurance provisions appropriately protect patients and families.